AuroMedics Pharma LLC recalls 59.5K vials of antipsychotic injection from US
AuroMedics Pharma LLC is recalling 59,500 vials of the injection on account of "Discoloration; hazy solution found in one vial…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Aurobindo Pharma
Aurobindo Pharma aims to become debt free in three years sans Sandoz deal
In September last year, the $3 billion drug maker said its US subsidiary entered into an agreement to acquire commercial…
Glenmark recalls over two lakh cartons of product in US
According to the latest Enforcement Report by the US Food and Drug Administration (USFDA), Glenmark Pharmaceuticals Inc USA is…
Aurobindo Pharma gets USFDA nod for its expectorant tablets
The tablets are the generic version of RB Health (US) LLC's Mucinex tablet, the company said
Documents potentially misleading in Aurobindo Pharma’s Unit-VII: US FDA
Several lists of documents requested were either provided as incomplete, inaccurate and or explained with potentially misleading…
Dr Reddy’s halts worldwide supply of ranitidine
USFDA probing into the reported impurity N-nitrosodimethylamine in it at low levels
Aurobindo Pharma recalls over 2k bottles of lipid-lowering tablets from US
The reason for recall is"labeling; incorrect or missing lot and/or exp date; some bottles labelled with lot number 05318054B…
Aurobindo Pharma net surges 39.5 per cent to Rs 636 crore
Revenues stood at Rs 5,444.6 crore against Rs 4,250.3 crore and witnessed a strong growth of 28.1 per cent
Aurobindo Pharma has…
Pharma packaging: An evolving sphere
Pharma companies looking at newer methods and approaches to minimise packaging costs and yet meet important goals such as…
US FDA finds “significant violations” at India’s Strides plant
The drugmaker was caught trying to dispose quality-control records, the FDA said in a letter made public on July 16